Heart check: experimental drug evobrutinib put to the test
NCT ID NCT07214935
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 24 times
Summary
This study checked whether a single dose of evobrutinib, an experimental drug, changes the heart's electrical activity (QT interval) in 36 healthy adults. Participants received evobrutinib, a placebo, or another drug for comparison. The goal was to see if evobrutinib could cause heart rhythm problems, which is important for future patient safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nuvisan GmbH
Neu-Ulm, Germany
Conditions
Explore the condition pages connected to this study.